Life Beyond Lung Cancer - Johnson & Johnson’s Breathtaking Vision at ASCO 2025 #asco2025

1 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
As ASCO 2025 commenced in Chicago on Friday 30th May, pharmaphorum headed over to the Windy City’s Willis Tower for Johnson & Johnson’s exclusive Breathtaking event on the 99th floor.

The cityscape surrounding the event far below, J&J launched its Breathtaking consumer activation for Rybrevant + Lazcluze, shining a spotlight on how this combination treatment gives patients more time to enjoy and cherish life’s most ‘breathtaking’ moments.

After the afternoon’s panel, pharmaphorum web editor Nicole Raleigh spoke with Biljana Naumovic, president, solid tumour, US oncology, at Johnson & Johnson, to discuss further the company’s intention to elevate awareness of the lung cancer patient journey with this direct-to-patient campaign and demonstrate how “life is more breathtaking than lung cancer.”

Naumovic explains Johnson & Johnson’s work in the lung cancer space, but also the company’s Oncology Care Index, which surveyed 500 oncologists, urologists, and Advanced Practice Providers (APPs) in the US.

You can soon find the panel discussion insights and more about the Oncology Care Index on pharmaphorum shortly, but, in the meantime, take a watch of this video interview direct from #ASCO25 to discover more.

https://pharmaphorum.com/spotlight/asco-2025
Category
Oncology
Be the first to comment

Up Next